Relay Therapeutics
Matt Delaney is an accomplished finance professional with extensive experience in financial planning and analysis. Currently serving as Vice President of Financial Planning & Analysis at Relay Therapeutics since January 2019, Matt has advanced through multiple roles, including Senior Director and Director within the same company. Prior to this, Matt held the position of Associate Director at Foundation Medicine from January 2017 to January 2019, and served as Manager of Financial Planning & Analysis at Nutraclick between January 2015 and December 2016. Matt's career began at EY, where key roles included Manager in Transaction Advisory Services and Senior in Assurance Services from September 2008 to December 2014. Matt earned a Master of Science in Accountancy from Bentley University in 2009, following a Bachelor of Science in Accountancy from the same institution in 2008. Early education was completed at Xaverian Brothers High School from 2000 to 2004.
Relay Therapeutics
1 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.